Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Blinded, Placebo-Controlled Extension to Study TRCA-301 to Evaluate the Long-term Safety and Durability of Effect of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis

NCT03390842 is registered in ClinicalTrials.gov with Tricida, Inc. as lead sponsor.

NCT NCT03390842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03390842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Blinded, Placebo-Controlled Extension to Study TRCA-301 to Evaluate the Long-term Safety and Durability of Effect of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis
Lead sponsor
Tricida, Inc.
Phase
Phase 3
Overall status
Completed
Start date
December 20, 2017
Completion date
February 22, 2019
Enrollment
196 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic acidosis